PROBIOTEC LTD Logo
AU000000PBP7
A0LCPC
PBP.AX

PROBIOTEC LTD

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2024, PROBIOTEC LTD has already paid €0.0444 in dividends. The last payout was in June 2024.

Financials

In the last year, PROBIOTEC LTD had revenue of €130.63M and net profit of €6.72M
(EUR) 2023
YoY
Revenue 130.63M 8.83%
Gross profit 37.6M 4.22%
Net profit 6.72M 25.47%
EBITDA 21.6M 5.32%

Fundamentals

Metric Value
Market capitalization
€151.04M
Number of shares
81.32M
52-week high/low
€1.89 - €1.33
Dividends No
Beta
0.47
P/E ratio
21.29
PEG ratio
0.21
P/B ratio
2.78
P/S ratio
1.13

Company profile

Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, ointments, and suspensions; powders and powder blending; and sprays, as well as manufactures and packages finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services pharmaceutical, consumer, healthcare, cosmetics, and food and beverage companies. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.

Name
PROBIOTEC LTD
CEO
Wesley Stringer CPA, LLB
Headquarters Laverton North, vic
Australia
Website
IPO
11/13/2006
Employees 111

Ticker symbols

Exchange Symbol
Australian Securities Exchange Ltd
PBP.AX
🍪

Parqet  uses cookies. Learn more